(Q38160948)

30 August 2017

0 references

Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets (English)

1 reference

non-alcoholic steatohepatitis

30 August 2017

0 references

1 reference

1 reference

1 reference

Z M Younossi

1

1 reference

30 August 2017

M J Reyes

2

1 reference

30 August 2017

A Mishra

3

1 reference

30 August 2017

R Mehta

4

1 reference

30 August 2017

L Henry

5

1 reference

30 August 2017

language of work or name

English

0 references

publication date

10 November 2013

1 reference

Alimentary Pharmacology & Therapeutics

30 August 2017

published in

1 reference

30 August 2017

volume

39

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

3-14

1 reference

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae

30 August 2017

cites work

1 reference

Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.

21 January 2018

1 reference

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease

21 January 2018

1 reference

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome

21 January 2018

1 reference

Metabolic syndrome and risk factors for non-alcoholic fatty liver disease

21 January 2018

1 reference

Pathophysiology of NASH: perspectives for a targeted treatment

21 January 2018

1 reference

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.

21 January 2018

1 reference

Current concepts and management approaches in nonalcoholic fatty liver disease.

21 January 2018

1 reference

Nonalcoholic fatty liver disease: current and potential therapies.

21 January 2018

1 reference

Non-invasive markers for hepatic fibrosis

21 January 2018

1 reference

Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women

21 January 2018

1 reference

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY).

21 January 2018

1 reference

Bach1 deficiency protects pancreatic β-cells from oxidative stress injury

21 January 2018

1 reference

Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

Transcutaneous vs. intraoperative quantitative ultrasound for staging bovine hepatic steatosis.

21 January 2018

1 reference

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

21 January 2018

1 reference

Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial

21 January 2018

1 reference

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.

21 January 2018

1 reference

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

21 January 2018

1 reference

The Effect of Metformin and Standard Therapy versus Standard Therapy alone in Nondiabetic Patients with Insulin Resistance and Nonalcoholic Steatohepatitis (NASH): A Pilot Trial

21 January 2018

1 reference

Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial

21 January 2018

1 reference

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

21 January 2018

1 reference

Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial

21 January 2018

1 reference

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

21 January 2018

1 reference

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

21 January 2018

1 reference

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial

21 January 2018

1 reference

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates

21 January 2018

1 reference

Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up

21 January 2018

1 reference

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

21 January 2018

1 reference

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

21 January 2018

1 reference

Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease.

21 January 2018

1 reference

Systemic symptoms in non-alcoholic fatty liver disease

21 January 2018

1 reference

Comparison of activity level among patients with chronic liver disease

21 January 2018

1 reference

American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise

21 January 2018

1 reference

Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism

21 January 2018

1 reference

Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease

21 January 2018

1 reference

Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.

21 January 2018

1 reference

Coffee, cirrhosis, and transaminase enzymes

21 January 2018

1 reference

Caffeine is protective in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach

21 January 2018

1 reference

Less Smad2 is good for you! A scientific update on coffee's liver benefits

21 January 2018

1 reference

Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery

21 January 2018

1 reference

Impact of coffee on liver diseases: a systematic review

21 January 2018

1 reference

Increased caffeine consumption is associated with reduced hepatic fibrosis

21 January 2018

1 reference

21 January 2018

1 reference

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

21 January 2018

1 reference

Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.

21 January 2018

1 reference

Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

21 January 2018

1 reference

Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism

21 January 2018

1 reference

Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.

21 January 2018

1 reference

Nonalcoholic fatty liver disease and bariatric surgery

21 January 2018

1 reference

Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients

21 January 2018

1 reference

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

21 January 2018

1 reference

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

21 January 2018

1 reference

Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study.

21 January 2018

1 reference

Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways

21 January 2018

1 reference

Association of caffeine intake and histological features of chronic hepatitis C

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12543

1 reference

30 August 2017

1 reference